Angiolipoma: Clinical Trials

2 trials for Angiolipoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Angiolipoma: new trials by email Literature Review of Angiolipoma trials Research Report on Angiolipoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
everolimus (RAD001) - Tuberous Sclerosis, Angiolipoma
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati202008-12-012013-09-18
Study of Kidney Tumors in Younger Patients
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor
CompletedChildren's Oncology Group80002006-02-272026-05-18

Narrower conditions

Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)  ·  Nephroma, Mesoblastic (1)  ·  Oncocytoma, renal (1)  ·  Tuberous Sclerosis (1)  ·  Wilms Tumor (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Adipose Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Congenital Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hamartoma (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Kidney Diseases (1)

Interventions

Everolimus (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  Children's Oncology Group (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Elizabeth A Mullen (1)  ·  John Bissler, MD (1)

Results publications

PMID 32267967, PMID 37933882, PMID 38396300, PMID 42657661

NIH funding

U10CA098543 (1), U10CA180886 (1), UG1CA189958 (1)